Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Adv Ophthalmol Optom. 2016 Aug;1(1):287–305. doi: 10.1016/j.yaoo.2016.03.007

Table 3.

Amblyopia treatment approaches: Historical versus current evidence-based approach

Historical Dogma Current Perspective
The mainstay of amblyopia
treatment
Patching Optimal refractive correction

Timing of refractive correction
and occlusion (patching or
atropine)
Simultaneous Occlusion prescribed subsequent to gains
from optical treatment effect

Patching dosage for moderate
amblyopia
Generally, the more the better; usually ≥
5–6 hours
Start with 2 hours; can increase dosage if
needed
Patching dosage for severe
amblyopia
Full-time or most waking hours Start with 6 hours; 2 hours is effective in
some cases

Atropine penalization use Patching failures only First-line treatment as alternative to
patching or for patching failures
Atropine penalization guidelines
  Amblyopia severity Only for moderate amblyopia Both moderate & severe cases
  Age of child Only in young children Younger and older children
Age after which amblyopia can
no longer be treated
Approximately 6–9 years of age Upper age limit not established; albeit
generally greater VA gains if <7 years of age

Recurrence of amblyopia after
treatment cessation in 9 to <13-
year-old children
High likelihood of regression Vast majority (>90%) do not regress